omeprazole has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 10 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, EL | 1 |
| Peravali, R | 1 |
| Patel, TS | 1 |
| Pozharashka, J | 1 |
| Dourmishev, L | 1 |
| Balabanova, M | 1 |
| Vassileva, S | 1 |
| Miteva, L | 1 |
| Almebayadh, M | 1 |
| Regnier-Rosencher, E | 1 |
| Carlotti, A | 1 |
| Goulvestre, C | 1 |
| Le Guern, V | 1 |
| Mouthon, L | 1 |
| Avril, MF | 1 |
| Dupin, N | 1 |
| Hung, R | 1 |
| Sangle, SR | 1 |
| Benton, E | 1 |
| D'Cruz, DP | 1 |
| McGibbon, D | 1 |
| Roman, J | 1 |
| Nguyen, KD | 1 |
| Dominguez, AR | 1 |
| Mankia, SK | 1 |
| Rytina, E | 1 |
| Burrows, NP | 1 |
| Toms-Whittle, LM | 1 |
| John, LH | 1 |
| Buckley, DA | 1 |
| Wee, JS | 1 |
| Natkunarajah, J | 1 |
| Marsden, RA | 1 |
| Bracke, A | 1 |
| Nijsten, T | 1 |
| Vandermaesen, J | 1 |
| Meuleman, L | 1 |
| Lambert, J | 1 |
| Dam, C | 1 |
| Bygum, A | 1 |
10 other studies available for omeprazole and Lupus Erythematosus, Cutaneous, Subacute
| Article | Year |
|---|---|
Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.
Topics: Aged, 80 and over; Autoantibodies; Biopsy; Humans; Lupus Erythematosus, Cutaneous; Male; Omeprazole; | 2020 |
Rowell's Syndrome Triggered by Omeprazole.
Topics: Aged; Erythema Multiforme; Female; Humans; Lupus Erythematosus, Cutaneous; Omeprazole; Proton Pump I | 2019 |
Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Esomeprazole; Female; Humans; Lupus Erythematosus, C | 2013 |
Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus.
Topics: Anti-Ulcer Agents; Female; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Mi | 2015 |
A diffuse desquamative rash in an elderly male.
Topics: Aged; Calcium Channel Blockers; Diagnosis, Differential; Diltiazem; Humans; Lupus Erythematosus, Cut | 2017 |
Omeprazole-induced subacute cutaneous lupus erythematosus.
Topics: Anti-Ulcer Agents; Drug Eruptions; Female; Gastroesophageal Reflux; Humans; Lupus Erythematosus, Cut | 2010 |
Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Drug Eruptions; Female; Humans; Lupus Erythematosus, Cut | 2011 |
A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
Topics: Aged; Anti-Ulcer Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Lupus Erythematosu | 2012 |
Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Diagnosis, Differential; Female; Humans; Lansoprazole | 2005 |
Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Autoantibodies; Duodenal Ulcer; Esophagitis; Female; Humans | 2008 |